Abstract
It is commonly known that iodinated contrast medium (CM) is a nephrotoxic agent and a frequent cause of acute kidney injury (AKI). However, there is debate as to whether contrast-associated AKI (CA-AKI) is clinically significant when weighed against the benefit of CM-enhanced imaging studies in the critically ill. This was a prospective observational study to assess whether the use of CM increases the incidence of clinically significant AKI in intensive care unit (ICU) patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
